Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- NDRA
- Price
- 3.53
- Stock movement up
- +0.02 (0.57%)
- Company name
- ENDRA Life Sciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 5.28M
- Ent value
- 6.28M
- Price/Sales
- 24.98
- Price/Book
- 30.84
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -21.99%
- 1 year return (CAGR)
- -29.54%
- 3 year return (CAGR)
- -91.97%
- 5 year return (CAGR)
- -75.72%
- 10 year return (CAGR)
- -
Last updated: 2026-02-20
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
NDRA does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 24.98 |
| Price to Book | 30.84 |
| EV to Sales | 29.69 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.50M |
| EPS (TTM) | -10.52 |
| FCF per share (TTM) | -6.70 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 211.60K |
| Gross profit (TTM) | -117.76K |
| Operating income (TTM) | -8.44M |
| Net income (TTM) | -8.01M |
| EPS (TTM) | -10.52 |
| EPS (1y forward) | -4.62 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -55.65% |
| Operating margin (TTM) | -3987.62% |
| Profit margin (TTM) | -3784.12% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 794.04K |
| Net receivables | 0.00 |
| Total current assets | 1.05M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.21M |
| Total assets | 1.96M |
| Accounts payable | 252.49K |
| Short/Current long term debt | 525.33K |
| Total current liabilities | 800.31K |
| Total liabilities | 1.79M |
| Shareholder's equity | 171.38K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.09M |
| Capital expenditures (TTM) | 17.28K |
| Free cash flow (TTM) | -5.10M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -4672.19% |
| Return on Assets | -407.68% |
| Return on Invested Capital | -2667.55% |
| Cash Return on Invested Capital | -1700.31% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.51 |
| Daily high | 3.62 |
| Daily low | 3.35 |
| Daily Volume | 16K |
| All-time high | 10412.50 |
| 1y analyst estimate | 30.00 |
| Beta | -0.04 |
| EPS (TTM) | -10.52 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NDRA | S&P500 | |
| Current price drop from All-time high | -99.97% | -1.82% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 22 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -74.19% | -10.84% |
| Avg time to new high | 134 days | 12 days |
| Max time to new high | 1043 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
5.28M
Marketcap category
Small-cap
Description
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Employees
21
Website
Investor relations
-
SEC filings
CEO
Francois Michelon
Country
USA
City
Ann Arbor
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page